These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 2698903
1. Double blind study of the pharmacodynamic and clinical activities of 5682 SE in venous insufficiency. Advantages of the new micronized form. Cospite M, Dominici A. Int Angiol; 1989; 8(4 Suppl):61-5. PubMed ID: 2698903 [Abstract] [Full Text] [Related]
3. Controlled studies of Daflon 500 mg in chronic venous insufficiency. Geroulakos G, Nicolaides AN. Angiology; 1994 Jun; 45(6 Pt 2):549-53. PubMed ID: 8203786 [Abstract] [Full Text] [Related]
4. Are the phlebotonic properties shown in clinical pharmacology predictive of a therapeutic benefit in chronic venous insufficiency? Our experience with Daflon 500 mg. Tsouderos Y. Int Angiol; 1989 Jun; 8(4 Suppl):53-9. PubMed ID: 2698902 [Abstract] [Full Text] [Related]
5. [Evaluation of clinical efficacy of a venotonic drug: lessons of a therapeutic trial with hemisynthesis diosmin in "heavy legs syndrome"]. Carpentier PH, Mathieu M. J Mal Vasc; 1998 Apr; 23(2):106-12. PubMed ID: 9608923 [Abstract] [Full Text] [Related]
6. Evaluation of the clinical pharmacological activity of a phlebotonic agent. Application to the study of Daflon 500 mg. Duchene Marullaz P, Amiel M, Barbe R. Int Angiol; 1988 Apr; 7(2 Suppl):25-32. PubMed ID: 3053940 [Abstract] [Full Text] [Related]
8. [A double-blind study comparing the clinical efficacy of the preparation F-117 (hidrosmin) versus diosmin in the treatment of patients with peripheral venous disorders]. Honorato Pérez J, Arcas Meca R. Rev Med Univ Navarra; 1990 Apr; 34(2):77-9. PubMed ID: 2130425 [Abstract] [Full Text] [Related]
11. Venous tone: are the phlebotonic properties predictive of a therapeutic benefit? A comprehensive view of our experience with Daflon 500 mg. Tsouderos Y. Z Kardiol; 1991 Apr; 80 Suppl 7():95-101. PubMed ID: 1792820 [Abstract] [Full Text] [Related]
13. [The chronobiology and clinical efficacy of Daflon in the treatment of chronic venous insufficiency]. Menyhelyi G, Acsády G, Hetényi A, Dubeaux D, Radó G. Ter Arkh; 1997 Apr; 69(4):46-8. PubMed ID: 9213959 [No Abstract] [Full Text] [Related]
14. [Hemorrhoids and conservative treatment. Review of the literature on the use of diosmin and micronized hesperidin]. La Torre F, Nicolai AP, Otti M. Minerva Chir; 1999 Dec; 54(12):909-16. PubMed ID: 10736998 [No Abstract] [Full Text] [Related]
15. Clinical efficacy of micronized purified flavonoid fraction: an overview. Struckmann JR. J Vasc Res; 1999 Dec; 36 Suppl 1():37-41. PubMed ID: 10474049 [Abstract] [Full Text] [Related]
16. [Therapeutic effectiveness of flavonoids illustrated by daflon 500 mg]. Hitzenberger G. Wien Med Wochenschr; 1997 Dec; 147(18):409-12. PubMed ID: 9454438 [Abstract] [Full Text] [Related]